The pivotal BETH (bevacizumab and trastuzumab Adjuvant Therapy in Her2-positive breast cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two
Febit’s new patented method is known as hybselect, targeted sequencing or sequence capture. Using this technique, researchers are able to isolate genes or genomic regions of interest from
The company believes that it is the first to file an abbreviated new drug application (ANDA) containing a paragraph IV certification for Entocort enteric coated (EC). Barr filed
The study was a Phase I, randomized, single blind, placebo-controlled, single center dose escalation study of a single bolus injection of IK-1001 in healthy volunteers to assess safety,
LifeCell, as the surviving corporation in the merger, is now a direct, wholly-owned subsidiary of KCI. KCI previously announced that it had acquired control of LifeCell pursuant to
NeoStem acquired the exclusive worldwide rights to very small embryonic-like (VSEL) stem cell technology developed by researchers at the University of Louisville in November 2007. NeoStem’s VSELs have
The ROI-T is a transforaminal approach implant with an anatomic shape that conforms to the anterior vertebral body, the minimal width and tapered end of the device facilitating
GenoLogics launched its Biomedical Informatics software solution to track observational studies, collect patient data at remote sites, provide biospecimen and clinical annotations management and facilitate researchers querying on
The import drug license (IDL) approved will enable BMP Sunstone to market and distribute Propess vaginal inserts that are 0.8mm thick. BMP’s Propess applicator improves efficacy and broadens
Geicam 9805 is the first taxane-based study to exclusively enroll women with node-negative early stage breast cancer considered to be at high risk for recurrence. The 1,059 women
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.